ID

32474

Description

Phase III Study of Neo-adjuvant Chemoradiotherapy Followed by Surgery for Squamous Cell Esophageal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01216527

Lien

https://clinicaltrials.gov/show/NCT01216527

Mots-clés

  1. 02/11/2018 02/11/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

2 novembre 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Squamous Cell Esophageal Carcinoma NCT01216527

Eligibility Squamous Cell Esophageal Carcinoma NCT01216527

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. histologic diagnosis of squamous cell thoracic esophageal carcinoma of stage iib or iii, which is potentially resectable.
Description

Squamous cell carcinoma of esophagus Thoracic Resectable TNM clinical staging

Type de données

boolean

Alias
UMLS CUI [1,1]
C0279626
UMLS CUI [1,2]
C0817096
UMLS CUI [1,3]
C1514888
UMLS CUI [1,4]
C3258246
2. patients must not have received any prior anticancer therapy.
Description

Cancer treatment Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0332197
3. more than 6 months of expected survival.
Description

Life Expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
4. age ranges from 18 to 70 years.
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
5. absolute white blood cells count ≥4.0×109/l, neutrophil ≥1.5×109/l, platelets
Description

White Blood Cell Count procedure | Neutrophil count | Platelet Count measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0023508
UMLS CUI [2]
C0200633
UMLS CUI [3]
C0032181
≥100.0×109/l, hemoglobin ≥90g/l, and normal functions of liver and kidney.
Description

Hemoglobin measurement | Liver function | Renal function

Type de données

boolean

Alias
UMLS CUI [1]
C0518015
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
6. karnofsky performance status (kps) of 90 or more.
Description

Karnofsky Performance Status

Type de données

boolean

Alias
UMLS CUI [1]
C0206065
7. signed informed consent document on file.
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. patients are diagnosed or suspected to be allergic to cisplatin or vinorelbine.
Description

Cisplatin allergy | Cisplatin allergy Suspected | Hypersensitivity Vinorelbine | Hypersensitivity Suspected Vinorelbine

Type de données

boolean

Alias
UMLS CUI [1]
C0570702
UMLS CUI [2,1]
C0570702
UMLS CUI [2,2]
C0750491
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0078257
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0750491
UMLS CUI [4,3]
C0078257
2. patients with concomitant hemorrhagic disease.
Description

Hemorrhagic Disorder

Type de données

boolean

Alias
UMLS CUI [1]
C0019087
3. pregnant or breast feeding.
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
4. inability to use gastric conduit after esophagectomy because of a prior surgery.
Description

Use of Conduit gastric Unable | Status post Esophagectomy | Etiology Operative Surgical Procedures Previous

Type de données

boolean

Alias
UMLS CUI [1,1]
C1524063
UMLS CUI [1,2]
C0441247
UMLS CUI [1,3]
C0038351
UMLS CUI [1,4]
C1299582
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C0085198
UMLS CUI [3,1]
C0015127
UMLS CUI [3,2]
C0543467
UMLS CUI [3,3]
C0205156
5. patients with concomitant peripheral neuropathy, whose ctc status is 2 or even more.
Description

Peripheral Neuropathy CTCAE Grades

Type de données

boolean

Alias
UMLS CUI [1,1]
C0031117
UMLS CUI [1,2]
C1516728
6. have a prior malignancy other than esophageal carcinoma, carcinoma in situ of the cervix, nonmelanoma skin cancer or cured early stage of prostate cancer.
Description

Malignant Neoplasms | Exception Esophageal carcinoma | Exception Carcinoma in situ of uterine cervix | Exception Skin carcinoma | Exception Prostate carcinoma Early stage Cured

Type de données

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0152018
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0851140
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0699893
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0600139
UMLS CUI [5,3]
C2363430
UMLS CUI [5,4]
C0679252

Similar models

Eligibility Squamous Cell Esophageal Carcinoma NCT01216527

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Squamous cell carcinoma of esophagus Thoracic Resectable TNM clinical staging
Item
1. histologic diagnosis of squamous cell thoracic esophageal carcinoma of stage iib or iii, which is potentially resectable.
boolean
C0279626 (UMLS CUI [1,1])
C0817096 (UMLS CUI [1,2])
C1514888 (UMLS CUI [1,3])
C3258246 (UMLS CUI [1,4])
Cancer treatment Absent
Item
2. patients must not have received any prior anticancer therapy.
boolean
C0920425 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Life Expectancy
Item
3. more than 6 months of expected survival.
boolean
C0023671 (UMLS CUI [1])
Age
Item
4. age ranges from 18 to 70 years.
boolean
C0001779 (UMLS CUI [1])
White Blood Cell Count procedure | Neutrophil count | Platelet Count measurement
Item
5. absolute white blood cells count ≥4.0×109/l, neutrophil ≥1.5×109/l, platelets
boolean
C0023508 (UMLS CUI [1])
C0200633 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
Hemoglobin measurement | Liver function | Renal function
Item
≥100.0×109/l, hemoglobin ≥90g/l, and normal functions of liver and kidney.
boolean
C0518015 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Karnofsky Performance Status
Item
6. karnofsky performance status (kps) of 90 or more.
boolean
C0206065 (UMLS CUI [1])
Informed Consent
Item
7. signed informed consent document on file.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Cisplatin allergy | Cisplatin allergy Suspected | Hypersensitivity Vinorelbine | Hypersensitivity Suspected Vinorelbine
Item
1. patients are diagnosed or suspected to be allergic to cisplatin or vinorelbine.
boolean
C0570702 (UMLS CUI [1])
C0570702 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0078257 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0750491 (UMLS CUI [4,2])
C0078257 (UMLS CUI [4,3])
Hemorrhagic Disorder
Item
2. patients with concomitant hemorrhagic disease.
boolean
C0019087 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
3. pregnant or breast feeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Use of Conduit gastric Unable | Status post Esophagectomy | Etiology Operative Surgical Procedures Previous
Item
4. inability to use gastric conduit after esophagectomy because of a prior surgery.
boolean
C1524063 (UMLS CUI [1,1])
C0441247 (UMLS CUI [1,2])
C0038351 (UMLS CUI [1,3])
C1299582 (UMLS CUI [1,4])
C0231290 (UMLS CUI [2,1])
C0085198 (UMLS CUI [2,2])
C0015127 (UMLS CUI [3,1])
C0543467 (UMLS CUI [3,2])
C0205156 (UMLS CUI [3,3])
Peripheral Neuropathy CTCAE Grades
Item
5. patients with concomitant peripheral neuropathy, whose ctc status is 2 or even more.
boolean
C0031117 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
Malignant Neoplasms | Exception Esophageal carcinoma | Exception Carcinoma in situ of uterine cervix | Exception Skin carcinoma | Exception Prostate carcinoma Early stage Cured
Item
6. have a prior malignancy other than esophageal carcinoma, carcinoma in situ of the cervix, nonmelanoma skin cancer or cured early stage of prostate cancer.
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0152018 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0699893 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C0600139 (UMLS CUI [5,2])
C2363430 (UMLS CUI [5,3])
C0679252 (UMLS CUI [5,4])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial